Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 15;390(2):111914.
doi: 10.1016/j.yexcr.2020.111914. Epub 2020 Mar 3.

Transchromosomic technology for genomically humanized animals

Affiliations
Free article
Review

Transchromosomic technology for genomically humanized animals

Takashi Moriwaki et al. Exp Cell Res. .
Free article

Abstract

"Genomically" humanized animals are invaluable tools for generating human disease models and for biomedical research. Humanized animal models have generally been developed via conventional transgenic technologies; however, conventional gene delivery vectors such as viruses, plasmids, bacterial artificial chromosomes, P1 phase-derived artificial chromosomes, and yeast artificial chromosomes have limitations for transgenic animal creation as their loading gene capacity is restricted, and the expression of transgenes is unstable. Transchromosomic (Tc) techniques using mammalian artificial chromosomes, including human chromosome fragments, human artificial chromosomes, and mouse artificial chromosomes, have overcome these limitations. These tools can carry multiple genes or Mb-sized genomic loci and their associated regulatory elements, which has facilitated the creation of more useful and complex transgenic models for human disease, drug development, and humanized animal research. This review describes the history of Tc animal development, the applications of Tc animals, and future prospects.

Keywords: Chromosome transfer; Human artificial chromosome; Human chromosome fragment; Humanized animal; Mouse artificial chromosome; Transchromosomic animal.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Mitsuo Oshimura is CEO and a shareholder of Trans Chromosomics Inc., Dr. Satoshi Abe is a member of Trans Chromosomics Inc.; other authors declare no conflict of interest.

Similar articles

Cited by

Publication types

LinkOut - more resources